Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab

PURPOSE: This study compared treatment patterns of Turkish patients with a diagnosis of rheumatoid arthritis (RA) who were treated with innovator Remicade(®) (infliximab [IFX]) and either continued IFX or switched to CT-P13. MATERIALS AND METHODS: Adult RA patients with ≥1 IFX claim were identified...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biologics
Auteurs principaux: Yazici, Yusuf, Xie, Lin, Ogbomo, Adesuwa, Ellis, Lorie A, Goyal, Kavitha, Teeple, Amanda, Simsek, Ismail
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207267/
https://ncbi.nlm.nih.gov/pubmed/30498332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S172337
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires